KBC Group NV Sells 834 Shares of Integer Holdings Corporation $ITGR

KBC Group NV lowered its holdings in Integer Holdings Corporation (NYSE:ITGR) by 51.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 792 shares of the medical equipment provider’s stock after selling 834 shares during the period. KBC Group NV’s holdings in Integer were worth $97,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nuveen LLC bought a new position in shares of Integer in the first quarter worth approximately $17,634,000. Millennium Management LLC increased its holdings in shares of Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares during the last quarter. Banco Santander S.A. purchased a new stake in shares of Integer during the 2nd quarter valued at $12,778,000. Emerald Advisers LLC lifted its holdings in shares of Integer by 1,542.0% during the 2nd quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock worth $12,767,000 after acquiring an additional 97,501 shares during the last quarter. Finally, Aberdeen Group plc grew its position in Integer by 38.5% in the second quarter. Aberdeen Group plc now owns 319,229 shares of the medical equipment provider’s stock worth $39,256,000 after acquiring an additional 88,784 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Trading Up 2.8%

ITGR opened at $70.02 on Friday. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $146.36. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The business has a 50 day simple moving average of $88.13 and a two-hundred day simple moving average of $105.20. The firm has a market capitalization of $2.45 billion, a price-to-earnings ratio of 29.30, a PEG ratio of 0.60 and a beta of 0.95.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company posted $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its Board of Directors has approved a stock buyback program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research reports. Truist Financial lowered their price target on Integer from $121.00 to $88.00 and set a “buy” rating on the stock in a research report on Friday, October 24th. KeyCorp dropped their target price on Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Integer in a research note on Friday, October 31st. Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 price target (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Finally, Wall Street Zen raised shares of Integer from a “hold” rating to a “buy” rating in a research note on Saturday. Four research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Integer currently has an average rating of “Hold” and an average price target of $96.75.

Insider Activity at Integer

In related news, Director Cheryl C. Capps acquired 1,600 shares of Integer stock in a transaction on Thursday, November 6th. The shares were acquired at an average cost of $66.70 per share, with a total value of $106,720.00. Following the transaction, the director owned 11,702 shares in the company, valued at $780,523.40. This trade represents a 15.84% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Tommy P. Thomas sold 884 shares of the firm’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total transaction of $62,012.60. Following the completion of the sale, the vice president directly owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. This represents a 19.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders acquired a total of 5,843 shares of company stock valued at $384,771 in the last 90 days. 2.16% of the stock is owned by company insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.